Literature DB >> 18769938

Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis.

Irene Esposito1, Andrea Kubisova, Adolf Stiehl, Hasan Kulaksiz, Peter Schirmacher.   

Abstract

Secondary sclerosing cholangitis (SSC) is a chronic cholestatic disorder caused by mechanical, infectious, toxic, or ischemic factors. A new variant of SSC occurring after long-term treatment in intensive care units (ICU) has been recently described and characterized from the clinical point of view. The aim of this study was the histomorphological characterization of ICU-treatment-related SSC (ICU-SSC) and the definition of histological changes occurring over time based on the morphological findings. Liver biopsies of ten patients affected by ICU-SSC obtained at different time points (1.5 to 57 months) after the initial injury were analyzed. The main morphological alterations included degenerative changes of portal bile ducts, portal edema, inflammation, and fibrosis as well as biliary interface activity and bilirubinostasis. Perivenular necroses and bile infarcts were found in eight and six patients, respectively. Bile duct loss was not observed. No correlation between morphological features of biopsies and liver chemistry tests or outcome could be established. Based on the morphological observation, a possible disease-progression model starting with an initial damage of portal bile ducts (primary insult) with associated portal/periportal changes (inflammation, ductular reaction) and resulting in secondary parenchymal changes is proposed.

Entities:  

Mesh:

Year:  2008        PMID: 18769938     DOI: 10.1007/s00428-008-0654-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  14 in total

Review 1.  AGA technical review on the evaluation of liver chemistry tests.

Authors:  Richard M Green; Steven Flamm
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

Review 2.  Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature.

Authors:  Einar Björnsson; Suresh T Chari; Thomas C Smyrk; Keith Lindor
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

3.  Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up.

Authors:  C Jaeger; G Mayer; R Henrich; L Gossner; T Rabenstein; A May; E Guenter; C Ell
Journal:  Endoscopy       Date:  2006-07       Impact factor: 10.093

Review 4.  Sclerosing cholangitis: a focus on secondary causes.

Authors:  Rupert Abdalian; E Jenny Heathcote
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

5.  Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases.

Authors:  W Scheppach; G Druge; G Wittenberg; J G Mueller; A M Gassel; H J Gassel; F Richter
Journal:  Crit Care Med       Date:  2001-02       Impact factor: 7.598

6.  Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms.

Authors:  Johannes Benninger; Rainer Grobholz; Yurdaguel Oeztuerk; Christoph H Antoni; Eckhart G Hahn; Manfred V Singer; Richard Strauss
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

Review 7.  Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.

Authors:  Andreas Geier; Peter Fickert; Michael Trauner
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2006-10

8.  Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders.

Authors:  S Engler; C Elsing; C Flechtenmacher; L Theilmann; W Stremmel; A Stiehl
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 9.  Sclerosing cholangitis.

Authors:  James Rl Maggs; Roger W Chapman
Journal:  Curr Opin Gastroenterol       Date:  2007-05       Impact factor: 3.287

10.  Poor outcome in progressive sclerosing cholangitis after septic shock.

Authors:  H Kulaksiz; D Heuberger; S Engler; A Stiehl
Journal:  Endoscopy       Date:  2008-02-11       Impact factor: 10.093

View more
  14 in total

1.  [Secondary sclerosing cholangitis after multiple trauma and long-term intensive care treatment: case report of a characteristic course].

Authors:  M Seemann; G Kirchner; S Bele; B Sinner; B Graf; M Kieninger
Journal:  Anaesthesist       Date:  2013-01-24       Impact factor: 1.041

2.  Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience.

Authors:  Ting Lin; Kai Qu; Xinsen Xu; Min Tian; Jie Gao; Chun Zhang; Ying Di; Yuelang Zhang; Chang Liu
Journal:  Front Med       Date:  2014-01-10       Impact factor: 4.592

3.  Secondary sclerosing cholangitis in a critically ill patient.

Authors:  Krista E Weiss; Juergen K Willmann; R Brooke Jeffrey; Terry S Desser
Journal:  Quant Imaging Med Surg       Date:  2016-04

Review 4.  Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.

Authors:  Pedro Martins; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2019-07-30

Review 5.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

6.  Liver transplantation for sclerosing cholangitis in a polytraumatized patient.

Authors:  Andreas A Schnitzbauer; Tung-Yu Tsui; Gabriele Kirchner; Marcus N Scherer; Thomas Bein; Hans J Schlitt; Aiman Obed
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-12-23

7.  Purine nucleoside phosphorylase deficiency with fatal course in two sisters.

Authors:  Caner Aytekin; Figen Dogu; Gonul Tanir; Deniz Guloglu; Ines Santisteban; Michael S Hershfield; Aydan Ikinciogullari
Journal:  Eur J Pediatr       Date:  2009-08-06       Impact factor: 3.183

8.  Secondary sclerosing cholangitis in critically ill patients after a traffic accident-a new entity that should be considered in death classification.

Authors:  Fred Zack; Horst Nizze; Verena Blaas; Anne Port; Andreas Büttner
Journal:  Int J Legal Med       Date:  2018-02-27       Impact factor: 2.686

Review 9.  Biliary cast formation with sclerosing cholangitis in critically ill patient: case report and literature review.

Authors:  O-nyoung Kwon; Seung Hyun Cho; Chang Keun Park; Sung Hee Mun
Journal:  Korean J Radiol       Date:  2012-04-17       Impact factor: 3.500

10.  Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.

Authors:  Simon Bütikofer; Daniela Lenggenhager; Pedro D Wendel Garcia; Ewerton M Maggio; Martina Haberecker; Cäcilia S Reiner; Gregor Brüllmann; Philipp K Buehler; Christoph Gubler; Beat Müllhaupt; Christoph Jüngst; Bernhard Morell
Journal:  Liver Int       Date:  2021-07-04       Impact factor: 8.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.